Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acetazolamide Oral Rinse for Soda Consumption
NCT06110078Phase 1Enrolling by invitation
- Sponsor
- University of Arizona
- Start
- Jan 2024
- Primary completion
- May 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of acetazolamide in obesity (4 arms), sponsored by University of Arizona. Primary endpoint: Soda intake at 3 weeks. Started Jan 2024; status: enrolling by invitation.
02
Drugs
acetazolamide
03
Conditions
obesity
Beyond the preview
Go deeper on NCT06110078.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06110078.